The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| AQUABOUNTY TECHNOLOGIES INC | COM NEW | 03842K200 | 2,094 | 837,554 | SH | SOLE | 837,554 | 0 | 0 | ||
| AQUABOUNTY TECHNOLOGIES INC | COM NEW | 03842K200 | 20,598 | 8,239,199 | SH | DFND | 8,239,199 | 0 | 0 | ||
| ENERGY TRANSFER LP | COM UT LTD PTN | 29273V100 | 14,048 | 1,073,990 | SH | SOLE | 1,073,990 | 0 | 0 | ||
| ENTERPRISE PRODS PARTNERS L | COM | 293792107 | 32,459 | 1,135,734 | SH | SOLE | 1,135,734 | 0 | 0 | ||
| FIBROCELL SCIENCE INC | COM | 315721407 | 3,631 | 1,226,766 | SH | SOLE | 1,226,766 | 0 | 0 | ||
| FIBROCELL SCIENCE INC | COM | 315721407 | 1,263 | 426,720 | SH | DFND | 426,720 | 0 | 0 | ||
| HALOZYME THERAPEUTICS INC | COM | 40637H109 | 150,541 | 9,706,087 | SH | SOLE | 9,706,087 | 0 | 0 | ||
| INTREXON CORP | COM | 46122T102 | 428,902 | 74,982,918 | SH | SOLE | 74,982,918 | 0 | 0 | ||
| NUSTAR ENERGY LP | UNIT COM | 67058H102 | 4,112 | 145,200 | SH | SOLE | 145,200 | 0 | 0 | ||
| ORAGENICS INC | COM PAR | 684023302 | 54 | 100,056 | SH | SOLE | 100,056 | 0 | 0 | ||
| ORAGENICS INC | COM PAR | 684023302 | 782 | 1,448,110 | SH | DFND | 1,448,110 | 0 | 0 | ||
| PTC THERAPEUTICS INC | COM | 69366J200 | 4,652 | 137,551 | SH | SOLE | 137,551 | 0 | 0 | ||
| QUAKER CHEM CORP | COM | 747316107 | 204 | 1,290 | SH | SOLE | 1,290 | 0 | 0 | ||
| TC PIPELINES LP | UT COM LTD PRT | 87233Q108 | 3,945 | 97,000 | SH | SOLE | 97,000 | 0 | 0 | ||